NCT05415397View on ClinicalTrials.gov

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

PHASE3RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Depressive Disorder, MajorInflammation
Interventions
DRUG

Celecoxib 400mg

Celecoxib add-on (400mg daily) add-on to treatment as usual (standard antidepressant treatment)

DRUG

Placebo

Placebo add-on to treatment as usual (standard antidepressant treatment)

Trial Locations (1)

1081 HJ

RECRUITING

Department of Psychiatry Amsterdam UMC, Amsterdam

All Listed Sponsors
collaborator

Netherlands Brain Foundation

OTHER

lead

Amsterdam UMC, location VUmc

OTHER